Skip to main content
SpringerLink
Log in

Inflammatory activation following interruption of long-term cardiac resynchronization therapy

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Previous observations suggest that cardiac resynchronization therapy (CRT) may exert an anti-inflammatory effect. The objective of this study was to evaluate the effect of temporary interruption of long-term CRT on plasma concentrations of proinflammatory cytokines and brain natriuretic peptide (BNP). The study group consisted of 54 patients (32 male and 22 female, mean age 64 years) with chronic heart failure (HF) treated with CRT. BNP, high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), and neopterin were measured three times: after 26–28 weeks of continuous CRT (CRT-on), 48 h after its cessation (CRT-off), and 48 h after switching the CRT-on again. CRT interruption resulted in a significant worsening of left ventricular systolic function: reduction of cardiac output (CO), dP/dt, and left ventricular ejection fraction (LVEF), as well as deterioration of mitral regurgitation in the CRT responder group. A significant increase in serum concentrations of hs-CRP, neopterin, IL-6, and BNP was noted in this subpopulation. In CRT nonresponders, no significant changes were observed. In responders the changes in serum concentrations of hs-CRP, IL-6, neopterin, and BNP, following CRT interruption, significantly correlated with the respective changes in thoracic fluid content (TFC) and inversely correlated with LVEF changes. Even short (48 h) interruption of long-term CRT led to a significant increase of proinflammatory cytokines and BNP concentrations in responders. The changes in hs-CRP, IL-6, neopterin, and BNP concentrations correlated with the change in TFC-marker of pulmonary congestion and inversely correlated with the change in LVEF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297:2502–2514

    Google Scholar 

  2. Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA (2008) The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels 23:217–223

    Article  PubMed  Google Scholar 

  3. Donal E, Leclercq C, Linde C, Daubert JC (2006) Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 27:1018–1025

    Article  PubMed  Google Scholar 

  4. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206

    Article  PubMed  CAS  Google Scholar 

  5. Wang Y, Zhou Y, Meng L, Lu X, Ou N, Li X (2009) Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol 49:591–599

    Article  PubMed  CAS  Google Scholar 

  6. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C (2007) Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121:68–73

    Article  PubMed  CAS  Google Scholar 

  7. Lappegard KT, Bjornstad H (2006) Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol 29:753–758

    Article  PubMed  Google Scholar 

  8. Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, Kolokathis F, Paraskevaidis IA, Leftheriotis D, Kremastinos DT (2006) Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol 29:255–261

    Article  PubMed  Google Scholar 

  9. Knight BP, Desai A, Coman J, Faddis M, Yong P (2004) Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44:72–77

    Article  PubMed  Google Scholar 

  10. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN (2010) Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 121:1985–1991

    Article  PubMed  Google Scholar 

  11. Woltjer HH, Bogaard HJ, de Vries PM (1997) The technique of impedance cardiography. Eur Heart J 18:1396–1403

    Article  PubMed  CAS  Google Scholar 

  12. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP (2002) Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105:438–445

    Article  PubMed  Google Scholar 

  13. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ (2007) Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50:2071–2077

    Article  PubMed  Google Scholar 

  14. Ypenburg C, Van Bommel RJ, Marsan NA, Delgado V, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ (2008) Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony. Am J Cardiol 102:718–721

    Article  PubMed  Google Scholar 

  15. Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D (2009) Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Echocardiography 26:759–765

    Article  PubMed  Google Scholar 

  16. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278–1283

    Article  PubMed  CAS  Google Scholar 

  17. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663

    Article  PubMed  CAS  Google Scholar 

  18. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111:996–1005

    Article  PubMed  CAS  Google Scholar 

  19. Nakagomi A, Seino Y, Endoh Y, Kusama Y, Atarashi H, Mizuno K (2010) Upregulation of monocyte proinflammatory cytokine production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure. J Card Fail 16:562–571

    Article  PubMed  CAS  Google Scholar 

  20. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J 31:1624–1632

    Article  PubMed  CAS  Google Scholar 

  21. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76

    Article  PubMed  CAS  Google Scholar 

  22. Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X, Heras M, Sanz G (2000) Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19:419–425

    Article  PubMed  CAS  Google Scholar 

  23. Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T (2005) Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100:415–420

    Article  PubMed  Google Scholar 

  24. Jug B, Salobir BG, Vene N, Sebestjen M, Sabovic M, Keber I (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 24:271–276

    Article  PubMed  Google Scholar 

  25. Trachtenberg BH, Hare JM (2009) Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5:561–577

    Article  PubMed  Google Scholar 

  26. Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E (2011) Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 32:1390–1397

    Article  PubMed  CAS  Google Scholar 

  27. Kelly RA, Smith TW (1997) Cytokines and cardiac contractile function. Circulation 95:778–781

    Article  PubMed  CAS  Google Scholar 

  28. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241–247

    Article  PubMed  CAS  Google Scholar 

  29. Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:166–172

    Article  PubMed  CAS  Google Scholar 

  30. Ramasubbu K, Oliveira G, Torre-Amione G (2006) Novel therapies for heart failure: focus on anti-inflammatory strategies. Congest Heart Fail 12:153–159

    PubMed  CAS  Google Scholar 

  31. Oyama JI, Kudo Y, Maeda T, Node K, Makino N (2012) Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels. doi:10.1007/s00380-011-0220-7

  32. Miettinen KH, Lassus J, Harjola VP, Siirila-Waris K, Melin J, Punnonen KR, Nieminen MS, Laakso M, Peuhkurinen KJ (2008) Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 10:396–403

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Cardiology, Medical University of Lublin, 8 Jaczewskiego Street, Lublin, Poland

    Andrzej Rubaj, Piotr Ruciński, Krzysztof Oleszczak, Michał K. Trojnar, Maciej Wójcik, Andrzej Wysokiński & Andrzej Kutarski

Authors
  1. Andrzej Rubaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Piotr Ruciński
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krzysztof Oleszczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michał K. Trojnar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maciej Wójcik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrzej Wysokiński
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrzej Kutarski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michał K. Trojnar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubaj, A., Ruciński, P., Oleszczak, K. et al. Inflammatory activation following interruption of long-term cardiac resynchronization therapy. Heart Vessels 28, 583–588 (2013). https://doi.org/10.1007/s00380-012-0285-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-012-0285-y

Keywords

Search

Navigation